CMR to present at Medtech Showcase 2017

MedTech.jpg (1)

Cambridge, UK, 13th December 2016: Cambridge Medical Robotics Ltd, the private company developing a next-generation robotic system for universal minimal access surgery, today announces that Martin Frost, Chief Executive Officer, will be presenting at Medtech Showcase 2017 in San Francisco.

The CMR presentation will be at 3.15PM Pacific Time on Tuesday 10th January 2017. Medtech Showcase is hosted at Parc 55 San Francisco, Union Square.



Cambridge Medical Robotics
Martin Frost, Chief Executive Officer
Tel: +44 (0) 1223 755 300

Consilium Strategic Communications
Mary-Jane Elliott, Ivar Milligan
Tel: +44 20 3709 5700


About the CMR Versius surgical robotic system

The CMR Versius comprises a surgeon console, modular light-weight robotic arms and a range of wristed 5 mm instruments. The system uses state-of-the-art 3D high-definition imagery, significantly enhanced flexibility, and will incorporate force feedback to provide surgeons with life-like sensitivity.

The system overcomes obstacles to widespread adoption of robotic minimal access surgery, namely robot size, instrument size, versatility, port placement, cost and ease of use, allowing the system to be highly utilised and ultimately cost-comparable to manual laparoscopic surgery.


About Cambridge Medical Robotics Limited 

Cambridge Medical Robotics is a private company developing the next-generation universal robotic system for minimal access (or “keyhole”) surgery.

Our vision is to make minimal access surgery universally accessible and affordable by significantly expanding the range of procedures that can be performed robotically. This will transform the existing market for surgical robotics.

Global annual revenues for robot-assisted minimal access surgery are presently approximately $4 billion and are anticipated to reach $20 billion by 2025[1].

Cambridge Medical Robotics was formed in January 2014 and has its headquarters in Cambridge, United Kingdom. The company achieved the registration of its Quality Management System to ISO 13485:2003 by Underwriters Laboratories LLC® (‘UL’), and the status as a UL Registered Firm, in September 2015.

Investors in Cambridge Medical Robotics include ABB Technology Ventures, LGT Global, Cambridge Innovation Capital and Escala Capital.

For further information, please visit:

[1]Industry Forecast, Accuray Research